Latest News

ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin® at ESMO


WALTHAM, Mass.–(BUSINESS WIRE)–IMGN Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab in Combination with Carboplatin and Avastin® at ESMO

Source link

Related posts

运用2MC Method的、基于牙医40年临床经验发明的调节鼓膜内外压力平衡的产品“Flight Aid ”将于2019年9月16日发售

Newsemia

Gamer Diet And Its Effects On Our Bodies

Newsemia

Pressure mounts to widen access to medical products that may combat Covid-19

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World